When GLP1 levels fall, appetite suppression fades and food noise, the persistent mental preoccupation with eating, often returns within days
This study revealed that in patients with heart failure with preserved ejection fraction and obesity, treatment with semaglutide led to reduction in physical limitations and symptoms, enhanced weight loss, and improved exercise function, compared to placebo
The EU will likely see biosimilar entry around 2028-2029
GLP-1 is an injectable medication of a glucagon-like peptide antagonist that slows gastric emptying and reduces glucose absorption
Whilst acne is not listed as a recognised side effect in the UK Summary of Product Characteristics, some individuals report skin changes during treatment
Your dietitian or prescribing provider can help you build a breakfast routine that fits your appetite, your schedule, and your goals